Bile acid receptor: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 28: | Line 28: | ||
[[4qe6]] – hFXR LBD + CDC + nuclear receptor coactivator 2 peptide<br /> | [[4qe6]] – hFXR LBD + CDC + nuclear receptor coactivator 2 peptide<br /> | ||
[[4qe8]] – hFXR LBD + DM175 + nuclear receptor coactivator 2 peptide<br /> | [[4qe8]] – hFXR LBD + DM175 + nuclear receptor coactivator 2 peptide<br /> | ||
[[5iaw]] - hFXR LBD + nuclear receptor coactivator 2 peptide + modulator<br /> | |||
[[5q0x]], [[5q0y]], [[5q0z]], [[5q10]], [[5q11]], [[5q12]], [[5q13]], [[5q14]], [[5q16]], [[5q18]], [[5q19]], [[5q1a]], [[5q1b]], [[5q1c]], [[5q1d]], [[5q1e]], [[5q1f]], [[5q1g]], [[5q1h]], [[5q1i]], [[5q01]], [[5q0j]], [[5q0k]], [[5q0l]], [[5q0m]], [[5q0n]], [[5q0o]], [[5q0p]], [[5q0r]], [[5q0q]], [[5q0s]], [[5q0t]], [[5q0u]], [[5q0v]], [[5q0w]], [[5q17]] - hFXR LBD + coactivator peptide SRC-1 HD3 + ligand<br /> | |||
[[3fxv]], [[3gd2]], [[3okh]], [[3oki]], [[3olf]], [[3omk]], [[3omm]], [[3oof]], [[3ook]], [[3p88]], [[3p89]] – hFXR LBD (mutant) + non-steroidal agonist + nuclear receptor coactivator 1 peptide<br /> | [[3fxv]], [[3gd2]], [[3okh]], [[3oki]], [[3olf]], [[3omk]], [[3omm]], [[3oof]], [[3ook]], [[3p88]], [[3p89]] – hFXR LBD (mutant) + non-steroidal agonist + nuclear receptor coactivator 1 peptide<br /> | ||
[[1ot7]] – hFXR LBD + CDC derivative + RPGR-interacting protein peptide<br /> | [[1ot7]] – hFXR LBD + CDC derivative + RPGR-interacting protein peptide<br /> | ||